StratDeckABT
Abbott Laboratories
ABT✓Share
Healthcare · Medical Devices · United States
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Price103.09USD
1D+1.12%
Market cap178B
AnalystsBuy25
Next earnings14 Oct
Loading chart…
Trade ideas
- Opinionated - ValueTop Picks—Stronger than peersBuy25Board
Analysts
ConsensusBuy25
Mean score1.52
Mean target120.26+16.66%
Target range103.00–135.00
Value vs sector peers
#13 of 26 in HealthcareStronger than peers47
- Fwd P/E17.040
- P/B3.573
- Yield2.5%48
- P/E33.425
- Rev growth+13.0%84
Fundamentals
P/E33.4
Forward P/E17.0
Price / book3.49
Dividend yield2.47%
Beta0.59
52-week range81.97–137.4938/100
ADV (USD)888M
Relative volume1.0
10d avg volume8.06M
Revenue growth+13.00%
EPS growth-47.50%
Performance
1D+1.12%
7D-4.84%
1M-7.33%
3M+17.09%
6M-4.98%
YTD-16.19%
In the briefing and the feed
Briefing for 11 SeptNeither the briefing nor the research feed has named ABT.
Catalysts
Next earnings: 14 Oct
Trade idea history
- 8 SeptLong105.527Dpending2Wpending1Mpending
- 28 JulShort108.907D+3.16%2W-0.23%1M-2.47%
Get it by email
The board ABT sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.